Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 6/20 | 0.50 |
| ▸ | ESR2 | Q92731 | 5/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | CISD1 | Q9NZ45 | 2/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.44 |
| ▸ | ABAT | P80404 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | APP | P05067 | 1/20 | 0.42 |
| ▸ | NQO2 | P16083 | 2/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | GMNN | O75496 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3753407 | 1.00 | ESR1 (0.50) | ESR1ESR2MEN1KMT2ACISD1 | |
| SCHEMBL3755558 | 0.79 | ESR1 (0.54) | ESR1ESR2MEN1KMT2ACISD1 | |
| SCHEMBL3752963 | 0.79 | ESR1 (0.54) | ESR1ESR2MEN1KMT2ACISD1 | |
| SCHEMBL17836924 | 0.77 | FBP1 (0.48) | ESR1MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL11073623 | 0.77 | FBP1 (0.48) | ESR1MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL9245051 | 0.77 | FBP1 (0.48) | ESR1MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL27601792 | 0.75 | ESR1 (0.58) | ESR1ESR2MEN1KMT2ACISD1 | |
| SCHEMBL3752596 | 0.75 | ESR1 (0.50) | ESR1ESR2MEN1KMT2ACISD1 | |
| SCHEMBL3752599 | 0.75 | ESR1 (0.50) | ESR1ESR2MEN1KMT2ACISD1 | |
| SCHEMBL8854633 | 0.73 | ESR1 (0.60) | ESR1ESR2MEN1KMT2ACISD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8410302-B2 | Methoxyimino compounds and fungicide composition comprising same | KYUNG NONG CORPORATION (KR) | 2013-04-02 | — | — | US | disclosed |
| US-20100298593-A1 | METHOXYIMINO COMPOUNDS AND FUNGICIDE COMPOSITION COMPRISING SAME | KYUNG NONG CORPORATION (KR) | 2010-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100298593-A1 | METHOXYIMINO COMPOUNDS AND FUNGICIDE COMPOSITION COMPRISING SAME | CYP51A1, MSMO1, MTMR1 | ESR1 1473/4885ESR2 2967/4885MEN1 33/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.